SC 13G/A

AMENDMENT NO. 4 TO THE SCHEDULE 13G

Company: Corvus Pharmaceuticals, Inc.
Filed: February 18, 2020
Accession Number: 0000921895-20-000584

View Document ↗ View on SEC.gov ↗